NGENF Nervgen Consolidation continues Possible entry ahead Длинная

NervGen Pharma Corp.OTC

Описание

⋅ 18 авг 2021 г., 02:05

Nice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities

Entry target ~ 1.15-1.35 (1.25 average)

Interesting medical treatments currently in trials

Long term play

Ещё